The ReSPonD trial - rivastigmine to stabilise gait in Parkinson’s disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients…

Overview of attention for article published in BMC Neurology, December 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 1 X post from an account with 2,924 followers.

Background: Gait impairment is common in people with Parkinson's disease. There is a lack http://t.co/BXcMimVgiB

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.